Related Experiment Video
Updated: May 10, 2026
10:12
Protein Misfolding Cyclic Amplification of Prions
Published on: November 7, 2012
Using protein misfolding cyclic amplification generates a highly neurotoxic PrP dimer causing neurodegeneration
XiuJin Yang1, LiFeng Yang, XiangMei Zhou
1State Key Laboratories for Agrobiotechnology, Key Lab of Animal Epidemiology and Zoonosis, Ministry of Agriculture, National Animal Transmissible Spongiform Encephalopathy Laboratory, College of Veterinary Medicine, China Agricultural University, Beijing, 100193, China.
Journal of Molecular Neuroscience : MN
|June 18, 2013
Summary
Researchers created a neurotoxic prion protein (PrP) dimer that causes neurodegeneration in hamsters, mimicking prion diseases. This discovery offers a new model for studying these complex brain disorders.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Prion diseases are linked to the abnormal prion protein (PrPSc).
- The aggregation and insolubility of PrPSc suggest a more complex mechanism involving soluble intermediates.
- Understanding these intermediates is crucial for elucidating neurodegenerative pathways.
Purpose of the Study:
- To generate and characterize a soluble, neurotoxic form of the prion protein.
- To investigate the pathogenic potential of this novel PrP species.
- To establish a model for studying prion-induced neurodegeneration.
Main Methods:
- Recombinant hamster PrP (23-231) was amplified using protein misfolding cyclic amplification.
- 1-palmitoyl-2-oleoylphosphatidylglycerol was used to facilitate the formation of a PrP dimer.
- The generated PrP dimer was intracerebrally injected into wild-type hamsters.
Main Results:
- A neurotoxic PrP dimer with characteristics of PrPSc was successfully generated.
- Intracerebral injection of the PrP dimer induced neurodegeneration in hamsters.
- Clinical and histopathological findings closely resembled transmissible spongiform encephalopathies, with toxicity linked to cellular apoptosis.
Conclusions:
- A novel neurotoxic PrP dimer capable of causing neurodegeneration has been created.
- This PrP dimer serves as a valuable model for investigating the mechanisms underlying PrP-linked neurodegenerative diseases.
- The findings support the hypothesis that soluble PrP intermediates play a key role in prion pathogenesis.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:37The Unfolded Protein Response
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...